PDCD1 and neoplasm: ICIs act blocking Cytotoxic T-Lymphocyte Antigen 4 (CTLA4), Programmed cell death protein 1 (PD-1) and its ligand PD-L1, thereby activating an effective cytotoxic anti-tumor immune response.